A detailed history of Veery Capital, LLC transactions in Dexcom Inc stock. As of the latest transaction made, Veery Capital, LLC holds 4,004 shares of DXCM stock, worth $321,280. This represents 0.1% of its overall portfolio holdings.

Number of Shares
4,004
Previous 4,004 -0.0%
Holding current value
$321,280
Previous $453,000 40.84%
% of portfolio
0.1%
Previous 0.18%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 10, 2024

BUY
$75.49 - $124.16 $603 - $993
8 Added 0.2%
4,004 $496,000
Q3 2023

Oct 13, 2023

SELL
$86.06 - $137.93 $1,032 - $1,655
-12 Reduced 0.3%
3,996 $372,000
Q2 2023

Jul 13, 2023

SELL
$112.47 - $130.98 $29,242 - $34,054
-260 Reduced 6.09%
4,008 $515,000
Q2 2022

Jul 18, 2022

BUY
$67.99 - $132.89 $217,635 - $425,380
3,201 Added 300.0%
4,268 $318,000
Q1 2021

Apr 28, 2021

SELL
$84.79 - $104.74 $3,900 - $4,818
-46 Reduced 4.13%
1,067 $383,000
Q4 2020

Feb 08, 2021

BUY
$78.0 - $104.5 $86,814 - $116,308
1,113 New
1,113 $411,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $31B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Veery Capital, LLC Portfolio

Follow Veery Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Veery Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Veery Capital, LLC with notifications on news.